MYC and leukemia: Moreover, Following HMGCR inhibition with pitavastatin treatment, an attenuated oncogenic AKT1 signaling was evident along with the suppression of MYC signaling pathway expression via the loss of chromatin accessibility at the leukemia stem cell-specific long-range MYC enhancer.